课题基金 / 基金详情

Next generation anti-androgens for the treatment of castration-resistant prostate cancers

Next generation anti-androgens for the treatment of castration-resistant prostate cancers
用于治疗去势抵抗性前列腺癌的下一代抗雄激素
批准号：
251984
负责人：
Cherkasov Artem
金额：
$50.1万
依托单位：
Vancouver Coastal Health Research Institute
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2012
资助国家：
加拿大
项目状态：
已结题
起止时间：
2012-03-01 至 2017-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=251984&lang=en
关键词：
Androgen Receptor Chemical Genomics Computer-Aided Drug Design Drug Resistance Hormone Resistance Prostate Cancer Small Molecule Drugs

项目摘要

项目成果

Cherkasov Artem的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Prostate cancer is the most commonly diagnosed non-skin cancer in Canadian men and one of the leading causes of cancer-related death. If diagnosed early, when still confined to the prostate, it is frequently curable by surgery or radiotherapy. Treatment f
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COVID-19 Variant Network - Computer-aided discovery of synergistic drug combinations with Remdevisir for COVID-19 through mechanism-based drug repurposing and combinatorial organoid screening.
  • 批准号：
    443064
  • 项目类别：
    Operating Grants
  • 资助金额：
    $6.56万
  • 财政年份：
    2021
  • 负责人：
    Cherkasov Artem
  • 依托单位：
    University of British Columbia
COVID-19 Variant Supplement - Computer-aided discovery of synergistic drug combinations with Remdevisir for COVID-19 through mechanism-based drug repurposing and combinatorial organoid screening.
  • 批准号：
    443137
  • 项目类别：
    Operating Grants
  • 资助金额：
    $3.64万
  • 财政年份：
    2021
  • 负责人：
    Cherkasov Artem
  • 依托单位：
    University of British Columbia
Computer-aided discovery of synergistic drug combinations with Remdevisir for COVID-19 through mechanism-based drug repurposing and combinatorial organoid screening.
  • 批准号：
    429444
  • 项目类别：
    Operating Grants
  • 资助金额：
    $153.65万
  • 财政年份：
    2020
  • 负责人：
    Cherkasov Artem
  • 依托单位：
    University of British Columbia
Sex as a Biological Variable Supplement - Augmented Discovery of Potential Inhibitors of SARS-CoV-2 3CL Protease
  • 批准号：
    424703
  • 项目类别：
    Operating Grants
  • 资助金额：
    $3.64万
  • 财政年份：
    2020
  • 负责人：
    Cherkasov Artem
  • 依托单位：
    University of British Columbia
海外基金